Addyi Cost in Texas 2026: Prices, Insurance, Medicaid, and Compounded Flibanserin

What Does Addyi Actually Cost in Texas in 2026?

The cash price for brand-name Addyi (flibanserin 100 mg) at Texas retail pharmacies sits at roughly $880 per 30-tablet supply in 2026. That figure reflects the Sprout Pharmaceuticals manufacturer list price and has not changed materially since 2024. No generic flibanserin tablet has received FDA approval, so retail cash prices remain anchored to the brand.

Prices vary slightly by pharmacy network. A GoodRx search of major Texas chains such as CVS, Walgreens, and H-E-B Pharmacy shows a narrow cash-pay range of $840 to $895 per month, depending on which coupon code or discount program is applied. Those numbers assume no insurance involvement. If a commercial plan covers the drug and prior authorization is approved, your out-of-pocket cost drops to whatever your plan's tier-3 or specialty copay requires, which ranges from $30 to $150 per fill for most Texas PPO and HMO products.

Addyi won FDA approval on August 18, 2015, making it the first approved pharmacologic treatment for HSDD in premenopausal women. The prescribing information lists the standard dose as 100 mg taken once daily at bedtime, with alcohol avoidance and a mandatory Risk Evaluation and Mitigation Strategy (REMS) program. [1]

The key BEGONIA trial published in the Journal of Sexual Medicine (2014, N=949) showed that women receiving flibanserin 100 mg nightly reported a statistically significant increase in satisfying sexual events (SSEs) compared with placebo at 24 weeks (P<0.001). [2] That efficacy evidence anchors the clinical rationale for the drug's price point, though whether a nearly $900 monthly cost is justified is a conversation every prescriber should have with patients before writing the script.

Does Texas Medicaid Cover Addyi?

Texas Medicaid does not cover Addyi. The drug is excluded from the Texas Vendor Drug Program (VDP) formulary for all standard Medicaid populations. Coverage is not available even with a prior authorization request under current 2026 policy.

The Texas Health and Human Services Commission classifies Addyi outside covered benefit categories for its Medicaid managed care plans, including STAR, STAR+PLUS, and STAR Kids. The statutory basis is that sexual dysfunction drugs are excluded from Medicaid coverage under 42 U.S.C. § 1396r-8(d)(2), which gives states latitude to exclude drugs used for "cosmetic purposes or hair growth" and certain other classes. Most states, including Texas, have applied a similar exclusion to HSDD pharmacotherapy.

Patients enrolled in Texas Medicaid should not expect this to change in 2026 absent a federal legislative revision or a new Texas state plan amendment. The Texas Vendor Drug Program Formulary is updated quarterly, but flibanserin has remained off-list since FDA approval. [3]

Women on Medicaid who want treatment for HSDD should discuss non-pharmacologic options with their provider. The American College of Obstetricians and Gynecologists (ACOG) practice bulletin on sexual dysfunction notes that cognitive behavioral therapy and mindfulness-based interventions have evidence-supported efficacy for HSDD and carry no drug cost. [4] Referral to a certified sex therapist who accepts Medicaid may be a viable first step.

How Does Commercial Insurance Cover Addyi in Texas?

Most Texas commercial plans place Addyi on a specialty or non-preferred tier and require prior authorization (PA) before dispensing. Coverage is not automatic even when Addyi appears on a plan's formulary.

A PA for Addyi in Texas typically requires the prescriber to document: a confirmed diagnosis of HSDD using DSM-5 criteria, absence of a reversible medical cause, confirmation that the patient is premenopausal, and either a trial of non-pharmacologic therapy or a clinical reason why such a trial is not appropriate. [1] Some insurers additionally require documentation that the patient has been counseled about the alcohol restriction under the FDA REMS program.

The largest commercial carriers operating in Texas in 2026 each handle Addyi differently. Blue Cross Blue Shield of Texas lists flibanserin on its non-preferred brand tier for most employer-sponsored plans, with a typical copay of $80 to $150 per fill after PA approval. Aetna and UnitedHealthcare policies vary by specific plan design, with some fully excluding the drug and others covering it at specialty tier rates. Cigna's Texas formularies generally require PA and step therapy showing that the patient discussed psychological or relationship counseling.

Patients whose PA is denied have the right to appeal under Texas Insurance Code Chapter 4201 and, if the appeal fails, to request an Independent Review Organization (IRO) review. The Texas Department of Insurance maintains a list of certified IROs at tdi.texas.gov. [5]

The FDA REMS program for flibanserin requires pharmacies to be certified before dispensing and requires patients to acknowledge the alcohol interaction risk. [6] This certification step occasionally delays initial fills by two to five business days even after insurance approval.

Is Compounded Flibanserin Legal in Texas?

Compounded flibanserin is legal in Texas when prepared by a licensed 503A pharmacy operating under the Texas State Board of Pharmacy (TSBP) rules and applicable federal law. It is not the same product as FDA-approved Addyi, and patients should understand that compounded versions have not undergone the same FDA manufacturing review.

Section 503A of the Federal Food, Drug, and Cosmetic Act permits compounding pharmacies to prepare individualized prescriptions for patients when a valid prescriber-patient relationship exists. Texas 503A pharmacies must hold an active TSBP compounding license and must source flibanserin as an active pharmaceutical ingredient (API) from an FDA-registered supplier. [7] The pharmacy cannot compound a copy of a commercially available drug as a general business practice, but individual patient prescriptions generally meet the exemption.

The cost difference can be substantial. Compounded flibanserin at a Texas 503A pharmacy may run $80 to $200 per month depending on the formulation and the specific pharmacy's pricing, compared with the $880 list price for brand Addyi. Some telehealth platforms that operate in Texas partner directly with compounding pharmacies to offer flibanserin at the lower end of that range.

TSBP oversight is not theoretical. The board conducts compliance inspections and has sanctioned Texas pharmacies for improper compounding practices in past enforcement cycles. Patients choosing a compounding route should verify that the pharmacy holds an active Texas license at pharmacy.texas.gov. [8]

One clinical consideration: compounded flibanserin is not covered by the Sprout REMS program, so the prescribing conversation about alcohol avoidance and hypotension risk must happen at the provider level rather than through the pharmacist REMS certification process. Prescribers in Texas who order compounded flibanserin should document that alcohol-interaction counseling occurred in the medical record.

Can You Get Addyi via Telehealth in Texas?

Telehealth prescribing of flibanserin is legal in Texas, provided the prescriber holds a valid Texas medical license and establishes a prescriber-patient relationship that meets Texas Medical Board (TMB) standards.

Texas law does not require an in-person visit before a telehealth provider can prescribe Addyi, as long as the provider performs an adequate evaluation, documents the HSDD diagnosis using DSM-5 criteria, and reviews contraindications including concurrent CYP3A4 inhibitor use, hepatic impairment, and hypotension risk. [9] The TMB's 2020 amendments to telemedicine rules broadly aligned Texas with the standard that a telehealth visit can constitute a valid clinical encounter for prescription purposes.

Several national and Texas-based telehealth platforms currently offer flibanserin prescribing. These platforms typically pair with either a certified Addyi specialty pharmacy for the brand product or a partnered 503A compounding pharmacy for a lower-cost compounded version. Visit fees for the initial consultation range from $50 to $150 at most platforms, with follow-up visits often priced lower.

Patients should confirm that the telehealth provider is licensed in Texas and that the pharmacy they use is also licensed in Texas. Prescriptions written by an out-of-state provider without a Texas license are not valid for Texas pharmacies. [10]

What Are the Texas Addyi Savings Programs?

Sprout Pharmaceuticals operates a patient savings card program for Addyi that applies to commercially insured and cash-pay patients who are not enrolled in a government program such as Medicaid or Medicare.

The Sprout savings card works as a secondary payer. For commercially insured patients whose plan covers Addyi, the card covers copay amounts up to a defined monthly maximum, historically set at $75 per fill. Cash-pay patients receive a discount that reduces the retail price from $880 toward a lower out-of-pocket figure, though the exact discount varies by pharmacy and enrollment status.

To use the Sprout savings card in Texas, patients enroll at the Sprout-operated myAddyi.com portal. The card is activated at the time of the first fill and must be re-authorized annually. [11] Texas pharmacies that participate in the REMS program can process the savings card directly at the point of sale.

GoodRx and similar prescription discount services also apply to Addyi at Texas retail pharmacies. GoodRx codes typically yield prices between $840 and $880 before any manufacturer discount, which is close to list price because no generic alternative exists to drive competition. The marginal benefit of GoodRx over the Sprout savings card depends on individual plan design and should be calculated at the pharmacy counter before completing the transaction.

Mark Cuban's Cost Plus Drugs does not currently list flibanserin among its formulary products, so that platform is not an option for Texas patients as of mid-2025.

Clinical Efficacy: Why Does This Drug Cost So Much?

Understanding Addyi's price requires context about its clinical development. Sprout submitted flibanserin to the FDA three times before approval, and the FDA required a large REMS program as a condition of approval given the alcohol-hypotension interaction signal.

The BEGONIA trial (N=949 to 24 weeks) is the most cited efficacy study. Women randomized to flibanserin 100 mg nightly reported a mean increase of 0.7 SSEs per 28 days above placebo. [2] The drug also showed statistically significant improvements on the Female Sexual Distress Scale-Revised (FSDS-R) score, a patient-reported outcome measure for sexually related personal distress. [2]

A separate 52-week open-label safety study published in the Journal of Sexual Medicine confirmed that the tolerability profile was consistent with the key trials, with dizziness (11.4%), somnolence (10.9%), and nausea (10.4%) as the most common adverse events. [12] These rates are meaningfully higher than placebo and are one reason the bedtime dosing requirement exists.

The Endocrine Society clinical practice guideline on female sexual dysfunction states that flibanserin "may be considered" for premenopausal women with HSDD who have not responded to psychotherapy, specifically noting that patient selection should weigh the modest effect size against the interaction risks. [13] The guideline does not recommend Addyi as a first-line agent.

Patients sometimes ask whether estrogen therapy or testosterone therapy addresses HSDD more effectively. Neither systemic estrogen nor testosterone is FDA-approved for HSDD in premenopausal women, though off-label testosterone use is discussed in guidelines as an option for postmenopausal women. [14] For premenopausal women, flibanserin remains the only FDA-approved pharmacologic option.

Drug Interactions and Safety: What Texas Prescribers Must Document

Flibanserin carries a boxed warning for severe hypotension and syncope when combined with alcohol or CYP3A4 inhibitors, and this warning directly shapes how Texas providers must document prescriptions.

The FDA requires that prescribers, pharmacies, and patients all be enrolled in the Addyi REMS (called the Addyi REMS Program) before a prescription can be dispensed at a certified pharmacy. [1] The prescriber certification involves a brief online module. Texas Medical Board rules require that prescribers maintain records of the REMS certification.

Common CYP3A4 inhibitors that Texans may be taking concurrently include fluconazole, certain HIV antiretrovirals, and some antifungals. Flibanserin plasma concentrations increase by approximately 7-fold with concomitant strong CYP3A4 inhibitors, according to the FDA label pharmacokinetic data. [1] That interaction is a clinical contraindication, not a warning to manage around.

Hepatic impairment of any degree is also a contraindication. Women with elevated liver enzymes or a known liver condition should not receive flibanserin. [1]

The HealthRX clinical team recommends a structured pre-prescribing checklist for Texas telehealth providers ordering flibanserin: confirm premenopausal status, rule out CYP3A4 inhibitor co-medications, document liver function status if any hepatic history exists, complete REMS certification, counsel on alcohol avoidance with a minimum 2-hour separation from any alcohol consumption, and schedule a 4-week follow-up to assess tolerability before continuing. This checklist is not part of any published guideline but reflects the documentation standard that supports PA approvals and reduces liability in Texas telehealth practice.

Comparing Costs: Brand Addyi vs. Compounded Flibanserin vs. Behavioral Therapy

Texas patients deciding between options can organize their choices around three cost tiers and their respective tradeoffs.

Brand Addyi at $880 per month delivers an FDA-reviewed product with a pharmacist-administered REMS consultation and the Sprout savings card as a cost offset. It is appropriate when a commercial plan covers it, the savings card reduces the net price substantially, and the patient wants the certainty of a branded, standardized formulation.

Compounded flibanserin at $80 to $200 per month delivers a lower-cost alternative that is legal in Texas under 503A pharmacy rules. The compound is not FDA-approved as a finished product, the formulation may vary between pharmacies, and REMS counseling is the prescriber's responsibility rather than the pharmacist's. It is appropriate for cash-pay patients who cannot afford brand pricing and whose prescriber is willing to document REMS-equivalent counseling.

Behavioral therapy through a sex therapist or psychologist typically runs $100 to $250 per session, with multiple sessions needed over weeks to months. [4] Texas Medicaid may cover some counseling services. For patients whose HSDD has a significant psychological or relational component, ACOG and the Endocrine Society both recommend behavioral therapy as a first or concurrent intervention. [13]

A 2021 meta-analysis in the Journal of Sexual Medicine (N=16 randomized controlled trials, total participants N=4,377) found that psychotherapy produced effect sizes for HSDD outcomes comparable to pharmacotherapy when measured at 12 weeks, though longer-term adherence to therapy showed decline. [15] That data point matters for Texas patients trying to decide whether a $200 monthly cost for counseling or an $880 monthly cost for a drug produces better value.

How to Get Addyi in Texas: Step-by-Step

Getting a valid Addyi prescription in Texas requires a defined sequence of steps. Skipping any one of them commonly delays the first fill by one to three weeks.

Step one: establish care with a Texas-licensed provider, either in person (gynecologist, primary care, psychiatry) or via a telehealth platform licensed in Texas. Step two: complete a clinical evaluation documenting HSDD diagnosis under DSM-5 criteria, absence of reversible causes such as medication side effects or relationship distress alone, and confirmation of premenopausal status. Step three: the provider completes Addyi REMS prescriber certification if not already enrolled at addyirems.com. [1] Step four: the prescription is sent to a REMS-certified pharmacy; the patient completes the REMS patient enrollment form at the pharmacy. Step five: the patient applies the Sprout savings card at the pharmacy counter or presents a GoodRx coupon as applicable.

For compounded flibanserin, step three and four are replaced by: the provider sends the prescription to a licensed Texas 503A compounding pharmacy; no REMS enrollment is required at the pharmacy level, but the provider's documented counseling must be in the chart.